“Thank you for the clinical trials presentation you gave… I know [the information] will be a great help as we advise our PIs on their upcoming proposals.”
“Her talk was extremely helpful”
“Thank you very much for such an informative presentation”
Attendee feedback from an onsite research development conference
Who:
NIH grantees confused about Human Subjects & Clinical Trial projects, and the people who advise them.
When:
View on demand now
Cost:
$199
CME Learning Objectives:
At the end of this 1 hour 22 minute session, participants will be able to:
- Acquire an understanding of the NIH clinical trial changes, including the form changes, and why they came about
- Apply that knowledge to understand the difference between information that goes in the PHS Human Subjects & Clinical Trial Information Form versus information that goes in the Approach section of the Research Strategy
- Develop a fundable Approach section that aligns with the latest instructions & guidance in order to obtain funding for human subjects research
ACCREDITATION AND AMA CREDIT DESIGNATION STATEMENTS
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Massachusetts Medical Society and Meg Bouvier Medical Writing, LLC. The Massachusetts Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Massachusetts Medical Society and Meg Bouvier Medical Writing, LLC. The Massachusetts Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
The Massachusetts Medical Society designates this internet enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.